title: Practice guidelines for reversal of new and old anticoagulants.
authors: S Kate
authors: SK
authors: Hartman
authors: Jun
authors: J
authors: Teruya
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D016903:Drug Monitoring / Q000379:methods*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D000077425:Fondaparinux; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D011134:Polysaccharides / Q000008:administration & dosage / Q000009:adverse effects; D017410:Practice Guidelines as Topic; D011300:Preoperative Care / Q000379:methods*; D013927:Thrombosis / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000925:Anticoagulants; D011134:Polysaccharides; D014859:Warfarin; D006493:Heparin; D000077425:Fondaparinux